Creative Planning Jounce Therapeutics, Inc. Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$4.3 - $6.73 $257,092 - $402,379	-59,789 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$3.43 - $6.87 $2,061 - $4,128	-601 Reduced 1.0%	59,789 $371,000
Q4 2018 Feb 01, 2019	BUY	$2.69 - $6.71 $103,293 - $257,657	38,399 Added 174.61%	60,390 $204,000
Q3 2018 Oct 25, 2018	BUY	$6.5 - $8.37 $142,941 - $184,064	21,991 New	21,991 $143,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.